2012 annual financial data
Travere Therapeutics 2012 Operating cash flow growth
Direct answer
Operating cash flow growth was -5,585,081.63%.
Operating income was -30,235,187 USD and net income was -30,343,856 USD.
Operating cash flow was -2,736,739 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -30,235,187 USD
- Net income
- -30,343,856 USD
- Operating cash flow
- -2,736,739 USD